Healthcare / Health Information ServicesTSXV
$0.43
+0.01 (+2.38%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.0M · quality 52.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
70/100
B
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$31M
P/E
21.5x
↑EV/EBITDA
9.0x
↓ROE
16.9%
↑Gross Margin
83.3%
↑Debt/Equity
0.05
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.9%
FCF CAGR
+102.3%
FCF margin
25.8%
FCF / Net income
3.59x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $17.9M · net income $1.3M · FCF $4.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $17.9M | $17.9M | $16.5M | $13.8M | $12.8M |
| Net Income | $1.3M | $1.3M | $614569.00 | $-331970.00 | $-22401.00 |
| EBITDA | $3.2M | $3.2M | $2.3M | $1.0M | $1.6M |
| EPS | 0.01 | 0.01 | 0.01 | -0.01 | -0.00 |
| Gross Margin | 83.3% | 83.3% | 79.6% | 78.1% | 79.7% |
| Operating Margin | 12.5% | 12.5% | 7.3% | -1.0% | 2.3% |
| Net Margin | 7.2% | 7.2% | 3.7% | -2.4% | -0.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.05 | 0.05 | 0.07 | 0.06 | 0.05 |
| Current Ratio | 1.16 | 1.16 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $4.6M | $4.6M | $832510.00 | $1.0M | $559446.00 |
| Returns | |||||
| ROE | 16.9% | 16.9% | 8.1% | -4.3% | -0.3% |
| Valuation | |||||
| P/E | 21.50 | 21.50 | 56.00 | — | — |
| EV/EBITDA | 9.02 | 9.02 | 8.72 | 15.04 | 11.30 |
| P/B | 4.35 | 4.35 | 2.81 | 2.19 | 2.15 |
| Growth & Yield | |||||
| Revenue Growth | 8.8% | 8.8% | 19.0% | 8.3% | — |
| EPS Growth | 180.0% | 180.0% | 162.5% | -2415.7% | — |
| Dividend Yield | 2.3% | 2.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
39.7%
EPS terminal req.
$0.04
Spread vs growth
140.3%
5Y implied EPS CAGR
27.0%
EPS terminal req.
$0.05
Spread vs growth
153.0%
10Y implied EPS CAGR
18.2%
EPS terminal req.
$0.07
Spread vs growth
161.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+55.9%
Start / end P/E
56.0x → 30.7x
EPS bridge
0.01 → 0.01
Residual
-81.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.